Paper of the month
-
31.12.2021 December 2021: CDK4/6 inhibitors in the treatment of patients with early breast cancer
We are delighted to inform you that an overview of data on CDK4/6 inhibitors in the treatment of breast cancer has been published in Breast.
-
30.11.2021 November 2021: Survival analysis of the randomised phase III GeparOcto trial
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
-
31.10.2021 October 2021: Association of RAD51 with HRD and clinical outcomes in untreated TNBC
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.
-
30.09.2021 September 2021: iDFS and safety results of the randomized phase III GAIN-2 trial
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
-
30.08.2021 August 2021: Utility of the CPS + EG scoring system in TNBC patients treated with neoadjuvant chemotherapy
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer